Erratum : Efficient delivery of lentiviral vectors into resting human CD4 T cells (Gene Therapy (2014) 21 (444-449)) DOI:10.1038/gt.2014.5);Efficient delivery of lentiviral vectors into resting human CD4 T cells

Gene Therapy

Volumn 21, Issue 4, 2014, Pages 444-449

  Geng, X ^a   Doitsh, G ^a   Yang, Z ^a   Galloway, N L K ^a   Greene, W C ^a,b  

^a GLADSTONE INSTITUTES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; CD4 T cells; HIV; lentivirus; shRNA; Vpx

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 1BETA CONVERTING ENZYME; LENTIVIRUS VECTOR; NIGERICIN; PROTEIN X; SHORT HAIRPIN RNA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE PRODUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA INTERFERENCE; TARGET CELL; TRANSGENE; VIRION; VIRUS CELL INTERACTION; VIRUS LIKE AGENT; ANIMAL; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; METABOLISM; PATHOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; RECEPTORS, CXCR4; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL PROTEINS;

EID: 84897574141     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2015.115     Document Type: Erratum

References (45)

1. Wambre E, James EA, Kwok WW. Characterization of CD4+ T cell subsets in allergy. Curr Opin Immunol 2012; 24: 700-706.
2. Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009; 41: 829-832.
3. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008; 134: 587-598.
4. Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV disease. Annu Rev Pathol 2011; 6: 223-248.
5. Glushakova S, Baibakov B, Margolis LB, Zimmerberg J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat Med 1995; 1: 1320-1322.
6. Suzuki H, Zelphati O, Hildebrand G, Leserman L. CD4 and CD7 molecules as targets for drug delivery from antibody bearing liposomes. Exp Cell Res 1991; 193: 112-119.
7. Wheeler LA, Trifonova R, Vrbanac V, Basar E, McKernan S, Xu Z et al. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras. J Clin Invest 2011; 121: 2401-2412.
8. Tahvanainen J, Pykalainen M, Kallonen T, Lahteenmaki H, Rasool O, Lahesmaa R. Enrichment of nucleofected primary human CD4+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation. J Immunol Methods 2006; 310: 30-39.
9. Eguchi A, Meade BR, Chang YC, Fredrickson CT, Willert K, Puri N et al. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat Biotechnol 2009; 27: 567-571.
10. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 1998; 9: 457-463.
11. Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med 2012; 18: 1682-1689.
12. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010; 143: 789-801.
13. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61: 213-222.
14. Zhou Y, Zhang H, Siliciano JD, Siliciano RF. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4 + T cells. J Virol 2005; 79: 2199-2210.
15. Swiggard WJ, O'Doherty U, McGain D, Jeyakumar D, Malim MH. Long HIV type 1 reverse transcripts can accumulate stably within resting CD4 + T cells while short ones are degraded. AIDS Res Hum Retroviruses 2004; 20: 285-295.
16. Swiggard WJ, Baytop C, Yu JJ, Dai J, Li C, Schretzenmair R et al. Human immunodeficiency virus type 1 can establish latent infection in resting CD4 + T cells in the absence of activating stimuli. J Virol 2005; 79: 14179-14188.
17. Dai J, Agosto LM, Baytop C, Yu JJ, Pace MJ, Liszewski MK et al. Human immunodeficiency virus integrates directly into naive resting CD4 + T cells but enters naive cells less efficiently than memory cells. J Virol 2009; 83: 4528-4537.
18. Derdouch S, Gay W, Negre D, Prost S, Le Dantec M, Delache B et al. Reconstitution of the myeloid and lymphoid compartments after the transplantation of auto-logous and genetically modified CD34 + bone marrow cells, following gamma irradiation in cynomolgus macaques. Retrovirology 2008; 5: 50.
19. Pace MJ, Graf EH, Agosto LM, Mexas AM, Male F, Brady T et al. Directly infected resting CD4 + T cells can produce HIV Gag without spreading infection in a model of HIV latency. PLoS Pathog 2012; 8: e1002818.
20. Wu Y, Marsh JW. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 2001; 293: 1503-1506.
21. Spina CA, Guatelli JC, Richman DD. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol 1995; 69: 2977-2988.
22. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E et al. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474: 654-657.
23. Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2000; 2: 308-316.
24. Agosto LM, Yu JJ, Liszewski MK, Baytop C, Korokhov N, Humeau LM et al. The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4 + T cells than the vesicular stomatitis virus glycoprotein G envelope. J Virol 2009; 83: 8153-8162.
25. Yu D, Wang W, Yoder A, Spear M, Wu Y. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells. PLoS Pathog 2009; 5: e1000633.
26. Negre D, Mangeot PE, Duisit G, Blanchard S, Vidalain PO, Leissner P et al. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 2000; 7: 1613-1623.
27. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci USA 2004; 101: 10380-10385.
28. Kreisberg JF, Yonemoto W, Greene WC. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J Exp Med 2006; 203: 865-870.
29. Plesa G, Dai J, Baytop C, Riley JL, June CH, O'Doherty U. Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4 + T cells. J Virol 2007; 81: 13938-13942.
30. Korin YD, Zack JA. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 1998; 72: 3161-3168.
31. White TE, Brandariz-Nunez A, Valle-Casuso JC, Amie S, Nguyen LA, Kim B et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013; 13: 441-451.
32. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
33. Doitsh G, Galloway NLK, Geng X, Yang Z, Monroe KM, Zepeda O et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505: 509-514.
34. Guo J, Wang W, Yu D, Wu Y. Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells. J Virol 2011; 85: 9824-9833.
35. O'Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000; 74: 10074-10080.
36. Berger G, Durand S, Goujon C, Nguyen XN, Cordeil S, Darlix JL et al. A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors. Nat Protoc 2011; 6: 806-816.
37. Bobadilla S, Sunseri N, Landau NR. Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Ther 2013; 20: 514-520.
38. Monroe KM, Yang Z, Johnson JR, Geng X, Doitsh G, Krogan NJ et al. IFI16 DNA Sensor Is Required for Death of Lymphoid CD4 T-cells Abortively Infected with HIV. Science 2014; 343: 428-432.
39. Siliciano RF, Greene WC. HIV latency. Cold Spring Harb Perspect Med 2011; 1: a007096.
40. Goujon C, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix JL, Cimarelli A. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther 2006; 13: 991-994.
41. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-6046.
42. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474: 658-661.
43. Wissing S, Montano M, Garcia-Perez JL, Moran JV, Greene WC. Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J Biol Chem 2011; 286: 36427-36437.
44. Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ et al. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5-and CXCR4-tropic HIV-1. AIDS 2007; 21: 1263-1272.
45. Cavrois M, De Noronha C, Greene WC. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 2002; 20: 1151-1154.